Nadine C. Landolina
Jerusalem, JM, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.
Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells.
Journal: Cancer gene therapy
Published: January 20, 2022
Activation of Siglec-7 results in inhibition of in vitro and in vivo growth of human mast cell leukemia cells.
Journal: Pharmacological research
Published: November 12, 2019
CD300a expression is modulated in atopic dermatitis and could influence the inflammatory response.
Journal: Allergy
Published: January 23, 2019
Siglec-7 on peripheral blood eosinophils: Surface expression and function.
Journal: Allergy
Published: July 06, 2018
Modulation of allergic responses by mitochondrial STAT3 inhibitors.
Journal: Allergy
Published: April 11, 2018
Mast cell and eosinophil surface receptors as targets for anti-allergic therapy.
Journal: Pharmacology & therapeutics
Published: October 30, 2016
Pyruvate dehydrogenase has a major role in mast cell function, and its activity is regulated by mitochondrial microphthalmia transcription factor.
Journal: The Journal of allergy and clinical immunology
Published: January 13, 2016
Monoclonal antibodies: the new magic bullets for allergy: IUPHAR Review 17.
Journal: British journal of pharmacology
Published: June 18, 2015
Mast cells' integrated actions with eosinophils and fibroblasts in allergic inflammation: implications for therapy.
Journal: Advances in immunology
Published: January 17, 2015
Eosinophils as a pharmacological target for the treatment of allergic diseases.
Journal: Current opinion in pharmacology
Published: March 06, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026